Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare…
Media ReleaseCOPENHAGEN, Denmark; November 24, 2025 Genmab A/S (Nasdaq:GMAB)announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Citi Global Healthcare Conference in Miamiat 9:45 AMEST(3:45PMCET)on December 4 , 2025 . A webcast of the fireside chat will be available on Genmab’s website athttps://ir.genmab.com/events-presentations. About Genmab Genmab is an...
Nasdaq GlobeNewswire
24/11/2025
Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart…
Technology convergence-where insulin delivery hardware integrates with continuous glucose monitors (CGMs), AI-based dosing algorithms, and smartphone dashboards-continues to drive strong adoption among younger diabetics, tech-savvy patients, and healthcare systems prioritizing long-term glycemic control. Technology convergence-where insulin delivery hardware integrates with continuous glucose monitors (CGMs), AI-based dosing algorithms, and smartphone dashboards-continues to drive strong...
PR Newswire
24/11/2025
Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically…
Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer’s disease. The two trials were randomised, double-blinded, enrolled a total of 3808 adults and evaluated the efficacy and safety of oral semaglutide compared to placebo on top of standard of care. The decision to pursue an Alzheimer’s disease indication with semaglutide was based on real-world…
Nasdaq GlobeNewswire
24/11/2025
Altibbi Enables Haleon's "Healthy Saudi Smile" Campaign, Turning Oral Health…
The campaign aimed to raise awareness about oral health and preventive care through engaging, science-based educational content. As the digital-health partner, Altibbi transformed this awareness into real access by connecting users directly with certified doctors for instant consultations and trusted medical guidance. The campaign aimed to raise awareness about oral health and preventive care through engaging, science-based educational content. As the digital-health partner, Altibbi…
PR Newswire
24/11/2025
Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads…
North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D. The United States remains at the forefront of CAR-T development, allogeneic platform research, and commercialization of next-generation therapies. North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D.The United...
PR Newswire
24/11/2025
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva®…
REYKJAVIK, ICELAND (November 25, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has approved AVT03 as a biosimilar to Prolia® and Xgeva® (denosumab).The European denosumab market is currently valued at approximately US$1.2 billion across all indications, based on originator sales in the last 12 months including the second quarter of...
Nasdaq GlobeNewswire
24/11/2025
Sectra at RSNA 2025: Supporting subspecialty workflows and photon-counting CT at…
"Radiologists are drowning in complexity-they need tools that simplify, not add more layers. With integrated photon-counting CT, AI-powered reporting, and subspecialty workflows built into the workstation, Sectra is delivering solutions that don't just reduce strain-they transform diagnostic speed and accuracy. At RSNA 2025, we're showcasing what it means to put radiologists back in control, while pushing patient care to new levels." "Radiologists are drowning in complexity-they…
PR Newswire
24/11/2025
Casino Group presents a detailed overview of “Renouveau 2030” plan and its…
Press ReleaseCasino Group presents a detailed overview of “Renouveau 2030” plan and its project to strengthen financial structure Project to adapt and strengthen Casino Group’s financial structure In support of the execution of its strategic plan, and given the maturity of its debt 1, the Group has initiated work on adapting and strengthening its financial structure. Assisted by the Court appointed administrators overseeing the implementation of the plan and the administrators...
Nasdaq GlobeNewswire
24/11/2025
DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting
Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP)Notice of 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that its Annual General Meeting is scheduled to take place on Thursday 18 thDecember at 11.30 at Elm House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB.For further information in relation...
Nasdaq GlobeNewswire
24/11/2025
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important…
Commercial traction:The Company met its objective of 40 ARC-EX ®Systems sold in Q3.Regulatory milestones:The US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the ARC-IM ®System, allowing the initiation of the Empower BP global pivotal study. The Company received CE Mark certification for the ARC-EX System. In November, the FDA also cleared the ARC-EX System for home use in the US.Science & technology leadership:Key...
Nasdaq GlobeNewswire
24/11/2025
/C O R R E C T I O N -- IEI Integration Corp./
TAIPEI, Nov. 21, 2025 /PRNewswire/ -- IEI Integration Corp. ("IEI"), a global provider of medical and industrial computing platforms, today announced that its New Taipei City (Xizhi) and Qidu (Keelung) facilities have passed inspection by the Taiwan Food and Drug Administration (TFDA) and been awarded Quality Management System (QMS) approval (Xizhi Certificate No. QMS2376、Keelung Certificate No. QMS2377), while maintaining ISO 13485:2016 certification. As one of Taiwan's manufacturers…
PR Newswire
24/11/2025
Sequana Medical Announces First U.S. Commercial alfapump® Implantation at Mount…
Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology community supports US market potential from this large and growing market driven by obesityKey step in validation of Sequana Medical’s strategy of targeting US transplant centers through its specialty commercial teamContinued strong progress in US commercial roll-outSequana Medical NV (Euronext Brussels: SEQUA, the...
Nasdaq GlobeNewswire
24/11/2025
Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and…
Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business Fagron, the global leader in pharmaceutical compounding, has reinforced its EMEA position with the acquisitions of a book of business from Amara (Poland) and Magilab (Hungary). These deals support Fagron’s strategy to diversify its...
Nasdaq GlobeNewswire
24/11/2025
Tony Adams Calls for a National Conversation During Addiction Awareness Week as…
Stigma remains a major barrier to accessing support: among those who have experienced addiction, 35% reported that they would be uncomfortable speaking about it with a close family member; 30% with a friend; 28% with their GP and 27% with their partner. Stigma remains a major barrier to accessing support: among those who have experienced addiction, 35% reported that they would be uncomfortable speaking about it with a close family member; 30% with a friend; 28% with their GP and 27% with their…
PR Newswire
24/11/2025
ANTAZERO X KRIS VAN ASSCHE Debuts Globally at Dover Street Market Paris
In the pop-up up at Dover Street Market Paris, the aesthetic language of ANTAZERO X KRIS VAN ASSCHE collection is seamlessly woven into the space, bringing in a restrained yet highly distinctive visual vision. Guests walk through a corridor dominated by deep black tones and encounter large-scale campaign visuals along the walls to feel the stylistic direction. The journey concludes in a minimalist space where visitors could experience the craftsmanship, materials, and the dialogue between sport…
PR Newswire
23/11/2025
Antlara Dental Introduces an AI assistant designed to help inform patients…
Spending hours upon hours poring over various search engine results pages is a thing of the past. Patients can ask the AI assistant anything they want about dental tourism to Turkey. Patients can also find comprehensive details regarding Antlara Dental's applications and services through the assistant. Spending hours upon hours poring over various search engine results pages is a thing of the past. Patients can ask theAI assistantanything they want about dental tourism toTurkey...
PR Newswire
21/11/2025
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper…
8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. Eastern Time (ET)Piper Sandler 37th Annual Healthcare Conference Wednesday, December 3, 2025, at 11:00 A.M. Eastern Time (ET)Citi’s 2025 Global Healthcare Conference Thursday, December 4, 2025, at 10:30 A.M. Eastern Time (ET) To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.An archived version of the...
Nasdaq GlobeNewswire
21/11/2025
Inventiva reports 2025 Third Quarter Financial Information¹
Cash and cash equivalents at €97.6 million, and €24.7 million in short-term deposits 2as of September 30, 2025.Revenues of €4.5 million for the first nine months of 2025.Cash runway expected until the end of the first quarter of 2027 3, including net proceeds from the November 2025 public offering.Daix (France), New York City, (New York, United States), November 21, 2025– Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage...
Nasdaq GlobeNewswire
21/11/2025
Healthcare Customer Relationship Management (CRM) Market Poised for Robust…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1052821 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1052821 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Healthcare Customer Relationship Management (CRM) Market Overview 1. Rising Need for Improved Patient Engagement The global Healthcare CRM market is expanding rapidly due to the increasing shift toward patient-centric...
PR Newswire
21/11/2025
Patient-Derived Xenograft/PDX Model Market worth US$0.66 billion by 2030 with…
Browse in-depth TOC on "PDX Model Market" Browse in-depth TOC on "PDX Model Market" 300 - Tables 50 - Figures 300 - Pages By type,the PDX model market is segmented into mouse models and rat models. The mouse model segment is expected to witness the highest growth rate during the forecast period, driven by its genetic similarity to humans, well-established immune-deficient strains, and proven reliability in replicating human tumor biology. Mouse PDX models provide high...
PR Newswire
21/11/2025
Prostate Cancer Drugs Market to Reach USD 28.10 Billion by 2033 | According to…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/prostate-cancer-drugs-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/prostate-cancer-drugs-market Browse in-depth TOC on "Prostate Cancer Drugs Market" 62 – Tables 57 – Figures 159 – Pages Market Outlook: Precision Oncology & Hormonal Innovation Continue to Reshape Global Demand Prostate cancer treatment has evolved significantly over the last decade...
PR Newswire
21/11/2025
From Vietnam to Italy to the Middle East: Better by MTA Expands Platinum Network…
Saudi German Health (MENA region) Saudi German Health (MENA region) Building on a long legacy as medical pioneers in the Kingdom, Saudi German Health was founded by the Batterjee family and has become one of the leading private healthcare providers across theMiddle EastandNorth Africa. Stretching across the MENA region, with a vast network of existing and upcoming hospitals and clinics acrossSaudi Arabia, UAE,Yemen,Egypt,MoroccoandPakistan, Saudi German Health is...
PR Newswire
21/11/2025
Blood Glucose Monitoring System Market worth US$25.4 billion by 2030 with 9.1%…
Browse in-depth TOC on "Blood Glucose Monitoring System Market" Browse in-depth TOC on "Blood Glucose Monitoring System Market" 250 - Tables 60 - Figures 310 - Pages By product type,the global blood glucose monitor market is divided into four main segments: self-monitoring blood glucose systems, continuous glucose monitoring systems, Professional Point of care devices, and noninvasive products. The self-monitoring blood glucose systems segment accounted for the largest...
PR Newswire
21/11/2025
OKYO Pharma Announces Chairman and Founder Acquires Shares
LONDON and NEW YORK, Nov.21, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announces that Panetta Partners Limited, an entity in which Gabriele Cerrone, Executive Chairman has a beneficial interest, has acquired 82,018 of the...
Nasdaq GlobeNewswire
21/11/2025
Altri Comunicati
